Mark G. Lewis

44.3k citations

193 papers · 9.2k indexed · 5 hit papers · h-index 50

Impact in

Virology top 0.05%
- HIV Research and Treatment
Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology

Papers in

Virology 132
- HIV Research and Treatment 130
Immunology 102
- Immune Cell Function and Interaction 61
- T-cell and B-cell Immunology 38
- Immunotherapy and Immune Responses 33

Co-authors: Thomas C. VanCott John R. Mascola Deborah L. Birx Hermann Katinger Gabriela Stiegler Sarah S. Frankel Chris E. Hanson Calvin B. Carpenter
Journals: Journal of Virology (23 papers)AIDS Research and Human Retroviruses (13 papers)Vaccine (11 papers)PLoS ONE (10 papers)AIDS (8 papers)
Partner nations: United States Italy France

In The Last Decade

Mark G. Lewis

190 papers receiving 8.9k citations

Hit Papers

5 papers align trajectories log scale

Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters 2022 · 119 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Med
2021 Nature Microbiology
2002 Nature
2000 Nature Medicine
1999 Journal of Virology

Peers

Countries citing papers authored by Mark G. Lewis

Since Specialization

Citations

This map shows the geographic impact of Mark G. Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Lewis more than expected).

Fields of papers citing papers by Mark G. Lewis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Lewis. The network helps show where Mark G. Lewis may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark G. Lewis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark G. Lewis Line = papers co-authored together Mark G. Lewis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaques Journal of Virology ·Joseph P. Nkolola, David Hope, Ruoran Guan, Alessandro Colarusso, Malika Aïd, Deborah Weiss, John Misamore, Hanné Andersen, Mark G. Lewis, Lauren E. Williamson, Robert H. Carnahan, James E. Crowe, Dan H. Barouch	2024	0
2	Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates Vaccines ·Bhawna Sharma, Elena Bekerman, Hoa Truong, Johnny W. Lee, Maria Gamez-Guerrero, Archana V. Boopathy, Rohit Mital, Katell Bidet Huang, Sarah Ahmadi-Erber, Raphaela Wimmer, Sophie Schulha, Henning Lauterbach, Klaus K. Orlinger, Silpa Suthram, Mark G. Lewis, Wade Blair, Tariro Makadzange, Romas Geleziunas, Jeffrey P. Murry, Sarah Schmidt	2024	1
3	Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques PLoS Pathogens ·Margherita Rosati, Mahesh Agarwal, Xintao Hu, Santhi Devasundaram, Dimitris Stellas, Bhabadeb Chowdhury, Jenifer Bear, Robert Burns, Duncan Donohue, Laurent Pessaint, Hanné Andersen, Mark G. Lewis, Evangelos Terpos, Meletios Α. Dimopoulos, Alexander Wlodawer, James I. Mullins, David Venzon, George N. Pavlakis, Barbara K. Felber	2021	12
4	Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques PLoS ONE ·Konstantin Virnik, Margherita Rosati, Alexei Medvedev, Aaron Scanlan, Gabrielle Walsh, Frances Dayton, Kate E. Broderick, Mark G. Lewis, Yvonne J. Bryson, Jeffrey D. Lifson, Ruth M. Ruprecht, Barbara K. Felber, Ira Berkower	2020	3
5	Lack of therapeutic efficacy of an antibody to α ₄ β ₇ in SIVmac251-infected rhesus macaques Science ·Peter Abbink, Noe B. Mercado, Joseph P. Nkolola, Rebecca Peterson, Hubert Tuyishime, Katherine McMahan, Edward T. Moseley, Erica N. Borducchi, Abishek Chandrashekar, Esther A. Bondzie, Arshi Agarwal, Aaron J. Belli, Keith A. Reimann, Brandon F. Keele, Romas Geleziunas, Mark G. Lewis, Dan H. Barouch	2019	18
6	Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy Nature Communications ·James B. Whitney, So‐Yon Lim, Christa E. Osuna, Jessica Kublin, Elsa Chen, Gyeol Yoon, Po-Ting Liu, Peter Abbink, Erica N. Borducci, Alison L. Hill, Mark G. Lewis, Romas Geleziunas, Merlin L. Robb, Nelson L. Michael, Dan H. Barouch	2018	44
7	TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy Science Translational Medicine ·So‐Yon Lim, Christa E. Osuna, Peter Hraber, Joe Hesselgesser, Jeffrey M. Gerold, Tiffany Barnes, Srisowmya Sanisetty, Michael S. Seaman, Mark G. Lewis, Romas Geleziunas, Michael D. Miller, Tomáš Cihlář, William A. Lee, Alison L. Hill, James B. Whitney	2018	116
8	Zika viral dynamics and shedding in rhesus and cynomolgus macaques Nature Medicine ·Christa E. Osuna, So‐Yon Lim, Claire Deléage, Bryan D. Griffin, Derek R. Stein, Lukas T Schroeder, Robert W. Omange, Katharine Best, Ma Luo, Peter Hraber, Hanne Andersen Elyard, E. Fabián Cardozo-Ojeda, Scott Huang, Dana L. Vanlandingham, Stephen Higgs, Alan S. Perelson, Jacob D. Estes, David Safronetz, Mark G. Lewis, James B. Whitney	2016	211
9	The Influence of Risk Perceptions and Efficacy Beliefs on Leisure-Time Physical Activity During Pregnancy Journal of Physical Activity and Health ·Christopher P. Connolly, James M. Pivarnik, Lanay M. Mudd, Deborah L. Feltz, Rebecca A. Schlaff, Mark G. Lewis, Robert M. Silver, Maria Knight Lapinski	2015	10
10	A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates PLoS neglected tropical diseases ·Karthik Mallilankaraman, Devon J. Shedlock, Huihui Bao, Omkar U. Kawalekar, Paolo Fagone, Aarthi A. Ramanathan, Bernadette Ferraro, Jennifer Stabenow, Paluru Vijayachari, Senthil G. Sundaram, Nagarajan Muruganandam, Gopalsamy Sarangan, Padma Srikanth, Amir Sada Khan, Mark G. Lewis, J. Joseph Kim, Niranjan Y. Sardesai, Kar Muthumani, David B. Weiner	2011	145
11	Smallpox Vaccine Does Not Protect Macaques with AIDS from a Lethal Monkeypox Virus Challenge The Journal of Infectious Diseases ·Yvette Edghill‐Smith, Mike Bray, Chris A. Whitehouse, David Miller, Eric M. Mucker, Jody Manischewitz, Lisa R. King, Marjorie Robert‐Guroff, Anna Hryniewicz, David Venzon, Clement A. Meseda, Jerry P. Weir, Ayşegül Nalça, Virginia Livingston, Jay Wells, Mark G. Lewis, John W. Huggins, Susan H. Zwiers, Hana Golding, Genoveffa Franchini	2005	75
12	Inverse Correlation of Telomerase Activity/Proliferation of CD4+ T Lymphocytes and Disease Progression in Simian Immunodeficiency Virus–Infected Nonhuman Primates JAIDS Journal of Acquired Immune Deficiency Syndromes ·Pavel Boštík, Gary T. Brice, Kenneth P. Greenberg, Ann E. Mayne, Francois Villinger, Mark G. Lewis, Aftab A. Ansari	2000	11
13	Titration and Characterization of Two Rhesus-Derived SIV _mac Challenge Stocks AIDS Research and Human Retroviruses ·Mark G. Lewis, Sharon Bellah, Katherine McKinnon, Jacob Yalley-Ogunro, Philip M. Zack, William R. Elkins, Ronald C. Desrosiers, Gerald A. Eddy	1994	81
14	Viral DNA Burden and Decline in Percentage of CD4-Positive Cells in the Lymphoid Compartment of SIV-Infected Macaques AIDS Research and Human Retroviruses ·Yvonne J. Rosenberg, Mark G. Lewis, Enrique C. Leon, Aurelio Cafaro, Gerald A. Eddy, Jack Greenhouse	1994	9
15	Immunological and Virological Changes Associated with Decline in CD4/CD8 Ratios in Lymphoid Organs of SIV-Infected Macaques AIDS Research and Human Retroviruses ·Yvonne J. Rosenberg, Philip M. Zack, Enrique C. Leon, Brian D. White, Sue F. Papermaster, Eric Hall, Jack Greenhouse, Gerald A. Eddy, Mark G. Lewis	1994	25
16	Association of Interleukin-6 in the Pathogenesis of Acutely Fatal SIV _smm/PBj-14 in Pigtailed Macaques* AIDS Research and Human Retroviruses ·Deborah L. Birx, Mark G. Lewis, MARYANNE VAHEY, KATHLEEN TENCER, PHILIP M. ZACK, CHARLES R. BROWN, Peter B. Jahrling, Giovanna Tosato, Donald S. Burke, Robert R. Redfield	1993	25
17	Decline in the CD4 ⁺ Lymphocyte Population in the Blood of SIV-Infected Macaques Is Not Reflected in Lymph Nodes AIDS Research and Human Retroviruses ·Yvonne J. Rosenberg, PHILIP M. ZACK, Brian D. White, Sue F. Papermaster, William R. Elkins, Gerald A. Eddy, Mark G. Lewis	1993	49
18	Infection of Rhesus and Cynomolgus Macaques with a Rapidly Fatal SIV (SIV _SMM/PBj ) Isolate From Sooty Mangabeys AIDS Research and Human Retroviruses ·Mark G. Lewis, Philip M. Zack, William R. Elkins, Peter B. Jahrling	1992	53
19	Vaccination of Macaques with SIV Conserved Envelope Peptides Suppressed Infection and Prevented Disease Progression and Transmission AIDS Research and Human Retroviruses ·Avigdor Shafferman, Mark G. Lewis, Francine E. McCutchan, Raoul Ė. Benveniste, Peter B. Jahrling, Robert L. Hickman, C Y. Lai, Donald S. Burke, Gerald A. Eddy	1992	6
20	Determination of mechanism of feline retroviral suppression of the feline immune system / OhioLink ETD Center (Ohio Library and Information Network) ·Mark G. Lewis	1983	1

About Mark G. Lewis

Mark G. Lewis is a scholar working on Virology, Immunology, Infectious Diseases, Epidemiology and Genetics, having authored 193 papers that have together received 9.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (130 papers), Immune Cell Function and Interaction (61 papers), T-cell and B-cell Immunology (38 papers), Immunotherapy and Immune Responses (33 papers), HIV/AIDS Research and Interventions (30 papers), Herpesvirus Infections and Treatments (26 papers), Virus-based gene therapy research (24 papers) and Cytomegalovirus and herpesvirus research (20 papers). The work is most often cited by research in Virology (5.2k citations), Immunology (4.1k citations), Infectious Diseases (3.4k citations), Epidemiology (2.5k citations) and Microbiology (244 citations). Mark G. Lewis has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Thomas C. VanCott, John R. Mascola, Deborah L. Birx, Hermann Katinger, Gabriela Stiegler, Sarah S. Frankel, Chris E. Hanson, Calvin B. Carpenter, Hanné Andersen and David C. Montefiori. Their work appears in journals such as Journal of Virology, AIDS Research and Human Retroviruses, Vaccine, PLoS ONE and AIDS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact